Compartilhar
Informação da revista
Os mais lidos
34495
Severe Relapsed Autoimmune Hemolytic Anemia after Booster with mRNA-1273 COVID-19 vaccineFlordeluna Z. Mesina
Hematol Transfus Cell Ther. 2024;46:485-8
34495
Acesso de texto completo
15638
Immune thrombocytopenia in a patient with essential thrombocythemia after SARS-CoV-2 infection: A case reportBarbora Bacova, Maria Maco, Lucie Geislerova, Ivana Zubata, Tomas Kozak, Jan Novak
Hematol Transfus Cell Ther. 2024;46:469-72
15638
Acesso de texto completo
13163
ABO blood group discrepancies in blood donor and patient samples at a tertiary care oncology centre: analysis and serological resolutionPriti Desai, Anisha Navkudkar, Sunil Rajadhyaksha
Hematol Transfus Cell Ther. 2024;46:402-7
13163
Acesso de texto completo
6575
ABO discrepancy resolution in two patients with acute myeloid leukemia presenting the transient weak expression of A antigenMarcos Paulo Miola, Tharsis Cardoso de Oliveira, Andrea Aparecida Garcia Guimarães, Octávio Ricci-Junior, Luiz Carlos de Mattos
Hematol Transfus Cell Ther. 2024;46:85-8
6575
Acesso de texto completo
6185
Sudden painless loss of vision as the initial manifestation of acute myeloid leukemia: a case reportVishal Mangal, Harshit Khurana, Deepti Mutreja, Navin Kumar Yadav, Phani Kumar Chakilam
Hematol Transfus Cell Ther. 2024;46:465-8
6185
Acesso de texto completo
6159
Anti-PF4 antibodies and their relationship with COVID infectionChieh Yang, Irene Wang, Akshit Chitkara, Jibin Swankutty, Rushin Patel, Samir V Kubba
Hematol Transfus Cell Ther. 2024;46:516-23
6159
Acesso de texto completo
5883
Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular TherapyLorena Lobo de Figueiredo-Pontes, Luiz Fernando Bazzo Catto, Maria de Lourdes Lopes Ferrari Chauffaille, Katia Borgia Barbosa Pagnano, Maria Isabel Ayrosa Madeira, Elenaide Coutinho Nunes, Nelson Hamerschlak, Marcela Cavalcante de Andrade Silva, ... Eduardo Magalhães Rego
Hematol Transfus Cell Ther. 2024;46:553-69
5883
Acesso de texto completo
5441
Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infectionRafael Peñuela, Indira Hernandez, Mónica Fernandes-Pineda, Lázaro Cortina, Diana Zapata, Olga Urrego, Juan Herrera, Isabel Saenz, ... Margarita Velazco
Hematol Transfus Cell Ther. 2024;46:506-10
5441
Acesso de texto completo
5431
Thrombocytopenic thrombotic purpura related to COVID-19 vaccine: apropos of 4 casesCélia Dos Santos, Santiago Castera, José Fernandez, Julieta Soledad Rosales, Franco Crescitelli, Santiago Boughen, Marcelo Iastrebner, Osvaldo Guerrero, ... Analía Sanchez-Luceros
Hematol Transfus Cell Ther. 2024;46:511-5
5431
Acesso de texto completo
5192
Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-upKaira Mara Cordeiro de Albuquerque, Caroline Brandão Joventino, Lia Correia Moreira, Hermano Alexandre Lima Rocha, Lívia Andrade Gurgel, Deivide de Sousa Oliveira, Carlos Ewerton Maia Rodrigues
Hematol Transfus Cell Ther. 2024;46:8-13
5192
Acesso de texto completo
4738
Characteristics of the post-surgical decrease in platelet counts in orthopedic surgery patients, observations and insightsGeorge Zacharia, Bartosz Walczyszyn, Kolton Smith, Guillaume Stoffels, Colette Spaccavento, Randy Levine
Hematol Transfus Cell Ther. 2024;46 Supl 5:S3-S7
4738
Acesso de texto completo
4572
Role of therapeutic plasma exchange as a desensitization therapy in human leukocyte antigen incompatible renal transplant patients: A single-center experienceMohit Chowdhry, Ayushi Yadav, Vandana Sharma, Soma Agrawal
Hematol Transfus Cell Ther. 2024;46:42-8
4572
Acesso de texto completo
4407
Coincidental or causal? A case report of acquired thrombotic thrombocytopenic purpura following mRNA-1273 Covid-19 vaccinationErinie M Mekheal, Christopher Millet, Nader Mekheal, Moutaz Ghrewati, Ashesha Mechineni, Michael Maroules
Hematol Transfus Cell Ther. 2024;46:489-93
4407
Acesso de texto completo
4323
Production of dendritic cell vaccines using different methods with equivalent results: Implications for emerging centersAdriana da Silva Santos Duarte, Audrey Basso Zangirolami, Irene Santos, Fernanda Soares Niemann, Helen Naemi Honma, Emerson Clayton Amaro, Maurício Wesley Perroud, Fernando Vieira Pericole, ... Sara Teresinha Olalla Saad
Hematol Transfus Cell Ther. 2024;46:30-5
4323
Acesso de texto completo
4113
Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALLAhmed Makboul, Walaa T. El-Mahdy, Doaa F. Temerik
Hematol Transfus Cell Ther. 2024;46:462-4
4113
Acesso de texto completo
3825
Epidemiology of immune thrombocytopenia: study of adult patients at a referral hematology service in Northeastern BrazilBruna Sobreira Kubrusly, Elsie Sobreira Kubrusly, Hermano Alexandre Lima Rocha, Antonio Brazil Viana Júnior, Marcela Sobreira Kubrusly, Lucas Loiola Ponte Albuquerque Ribeiro, Rosângela de Albuquerque Ribeiro, Fernando Barroso Duarte
Hematol Transfus Cell Ther. 2024;46 Supl 5:S152-S157
3825
Acesso de texto completo
3577
Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a case of leukocyte adhesion deficiency type IIIDima Barhoom, Maryam Behfar, Rashin Mohseni, Amir Ali Hamidieh
Hematol Transfus Cell Ther. 2024;46:300-2
3577
Acesso de texto completo
3556
All about blinatumomab: the bispecific T cell engager immunotherapy for B cell acute lymphoblastic leukemiaReza Mirfakhraie, Bentolhoda Kuhestani Dehaghi, Mahmoud Dehghani Ghorbi, Haniyeh Ghaffari-Nazari, Mozhdeh Mohammadian, Maryam Salimi, Maria Tavakoli Ardakani, Sayeh Parkhideh
Hematol Transfus Cell Ther. 2024;46:192-200
3556
Acesso de texto completo
3554
Flow cytometry immunophenotyping of healthy platelets and hospitalized patients with suspected platelet dysfunction: Challenges for establishing a cutoff valueDaiane Keller Cecconello, Fabiane Spagnol, Ana Paula Alegretti, Diogo André Pilger, Mariela Granero Farias
Hematol Transfus Cell Ther. 2024;46 Supl 5:S136-S142
3554
Acesso de texto completo
3513
Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severityBárbara Gomes Barion, Tania Rubia Flores da Rocha, Yeh-Li Ho, Bruna de Moraes Mazetto Fonseca, Erica Okazaki, Cynthia Rothschild, Bianca Stefanello, Vanderson Geraldo Rocha, ... Fernanda A. Orsi
Hematol Transfus Cell Ther. 2024;46:176-85
3513
Acesso de texto completo
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.